Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NER1008 vs Fleet Enema for Bowel Cleansing
NCT02468726Completed
- Sponsor
- Norgine
- Start
- Nov 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of NER1008 in Gastrointestinal cleansing (2 arms), sponsored by Norgine. Primary endpoint: Success of bowel cleansing at 3 hours. Started Nov 2011; status: completed.
02
Drugs
NER1008
03
Conditions
Gastrointestinal cleansing
Beyond the preview
Go deeper on NCT02468726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02468726.